Versor Investments LP Innoviva, Inc. Transaction History

Versor Investments LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$14.56 - $16.78 $117,936 - $135,918	8,100 Added 32.79%	32,800 $499,000
Q4 2023 Feb 07, 2024	SELL	$12.32 - $16.27 $27,104 - $35,794	-2,200 Reduced 8.18%	24,700 $396,000
Q3 2023 Nov 06, 2023	BUY	$12.37 - $13.89 $184,523 - $207,197	14,917 Added 124.48%	26,900 $349,000
Q2 2023 Aug 07, 2023	SELL	$11.39 - $13.72 $36,448 - $43,904	-3,200 Reduced 21.08%	11,983 $152,000
Q1 2023 May 05, 2023	BUY	$10.73 - $13.6 $5,182 - $6,568	483 Added 3.29%	15,183 $170,000
Q4 2022 Jan 30, 2023	SELL	$11.8 - $13.78 $319,237 - $372,804	-27,054 Reduced 64.79%	14,700 $194,000
Q3 2022 Oct 25, 2022	BUY	$11.61 - $15.22 $101,564 - $133,144	8,748 Added 26.5%	41,754 $485,000
Q2 2022 Jul 27, 2022	BUY	$14.32 - $19.88 $77,299 - $107,312	5,398 Added 19.55%	33,006 $487,000
Q1 2022 May 04, 2022	BUY	$15.39 - $20.25 $424,887 - $559,062	27,608 New	27,608 $534,000

229

79.2M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Versor Investments LP, based on Form 13F filings with the SEC.

Stay updated on Versor Investments LP with notifications on news.